AP
Acadia Pharmaceuticals
Resolving
Resolving brand mentions across new media
Acadia Pharmaceuticals
Resolving brand mentions across new media
Acadia Pharmaceuticals
4
Mentions
1.9K
Views
“A $4.5 billion neuroscience and rare disease pharmaceutical company.”
“Biotech firm focused on neuroscience and rare diseases.”
“Biotech firm focused on neuroscience and rare diseases.”
“Biopharmaceutical company focused on neuroscience and rare diseases.”
Arcmira media summary
Arcmira tracks where Acadia Pharmaceuticals is discussed across indexed YouTube videos, transcripts, channels, and related entities.
A $4.5 billion neuroscience and rare disease pharmaceutical company.
Biotech firm focused on neuroscience and rare diseases.
Biotech firm focused on neuroscience and rare diseases.
Biopharmaceutical company focused on neuroscience and rare diseases.
Arcmira tracks 4 indexed media appearances or mentions for Acadia Pharmaceuticals, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "Acadia CEO on the Fight Against Rare Diseases | Bloomberg Businessweek" with transcript-derived context and links when available.
Acadia Pharmaceuticals is connected to JPMorgan Healthcare Conference, Corporate Homebuying Ban, Bio in Arcmira's media graph.